Chemical Structure : WP1066
CAS No.: 857064-38-1
Catalog No.: PC-73189Not For Human Use, Lab Use Only.
WP1066 is a potent, cell-active STAT3 pathway inhibitor, inhibits human malignant glioma U87-MG and U373-MG cells in vitro with IC50 of 5.6 and 3.7 uM.
Packing | Price | Stock | Quantity |
---|---|---|---|
10 mg | $78 | In stock | |
25 mg | $118 | In stock | |
50 mg | $188 | In stock | |
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
WP1066 is a potent, cell-active STAT3 pathway inhibitor, inhibits human malignant glioma U87-MG and U373-MG cells in vitro with IC50 of 5.6 and 3.7 uM.
WP1066 activated Bax, suppressed the expression of c-myc, Bcl-XL and Mcl-1, and induced apoptosis.
WP1066 inhibited the growth of subcutaneous malignant glioma xenografts during the 30-day follow-up period via systemic intraperitoneal administration.
WP1066 inhibited the phosphorylation of JAK2 and also degraded JAK2 protein in AML cells, thereby blocking its downstream STAT and PI3K pathways.
M.Wt | 356.22 | |
Formula | C17H14BrN3O | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
(S,E)-3-(6-bromopyridin-2-yl)-2-cyano-N-(1-phenylethyl)acrylamide |
1. Iwamaru A, et al. Oncogene. 2007 Apr 12;26(17):2435-44.
2. Hussain SF, et al. Cancer Res. 2007 Oct 15;67(20):9630-6.
3. Ferrajoli A, et al. Cancer Res. 2007 Dec 1;67(23):11291-9.
4. Verstovsek S, et al. Clin Cancer Res. 2008 Feb 1;14(3):788-96.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright